For the study, immunized cohorts were again generated and at 9 weeks, sex and age-matched naïve and immunized mice were injected subcutaneously with 2 × 106 YUMM 2.1 ICAM-1 cells in the right flank and monitored for tumor growth for 7–10 days. This evidence concerns the gene ICAM1 and neoplasm.